Status:
RECRUITING
Rapid Assessment of Sentinel Lymph Node Metastasis Status Using a Pan-CK-targeting NIR-II Fluorescent Probe in Breast Cancer
Lead Sponsor:
Yunnan Cancer Hospital
Collaborating Sponsors:
Xiang'an Hospital of Xiamen University
Conditions:
Breast Cancer Metastatic
Sentinel Lymph Node
Eligibility:
FEMALE
18-75 years
Brief Summary
Breast malignant tumors are a serious threat to women's health, and the current treatment for breast malignant tumors is still dominated by surgery, but the problems faced by patients after surgery su...
Detailed Description
Following patient enrollment, surgical interventions were performed in accordance with standardized clinical protocols. During the operative procedure, the excised sentinel lymph nodes (SLNs) underwen...
Eligibility Criteria
Inclusion
- Adult patients between 18-75 years of age
- Patients presenting with a breast nodule or mass presumed to be resectable on pre-operative assessment
- Breast cancer patients who are scheduled to undergo sentinel lymph node biopsy or axillary lymph node dissection;
- Good operative candidate
- Subject capable of giving informed consent and participating in the process of consent
Exclusion
- Patients unable to participate in the consent process
- Patients had contraindications to surgery, such as serious cardiopulmonary disease, coagulation dysfunction, etc
Key Trial Info
Start Date :
February 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT07154563
Start Date
February 1 2025
End Date
December 1 2026
Last Update
September 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yunnan Cancer Hospital, Kunming, Yunnan 650118
Kunming, Yunnan, China